Given that we have previously demonstrated beneficial effects of pharmacological RhoA/ROCK inhibition on survival and neuromuscular phenotype of SMA mice [42,95], the RhoA/ROCK and GC signaling cascades may equally contribute to muscle and metabolic pathologies in SMA muscle. This evidence concerns the gene RHOA and proximal spinal muscular atrophy.